2024-12-19 |
2024-12-19 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
5,000
+2.3%
1.68
USD 8,400
|
5,000
+2.3%
|
1.68
|
USD 8,400
|
|
2024-12-19 |
2024-12-19 |
B
Purchase
|
Budd Haeberlein Samantha L.
Non-Executive Director
|
12,000
+inf%
1.71
USD 20,520
|
12,000
+inf%
|
1.71
|
USD 20,520
|
|
2024-12-18 |
2024-12-18 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
5,000
+2.4%
1.67
USD 8,350
|
5,000
+2.4%
|
1.67
|
USD 8,350
|
|
2024-12-05 |
2024-12-05 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
5,000
+2.4%
2.34
USD 11,700
|
5,000
+2.4%
|
2.34
|
USD 11,700
|
|
2023-11-20 |
2023-11-20 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
4,000
+2.0%
3.75
USD 15,000
|
4,000
+2.0%
|
3.75
|
USD 15,000
|
|
2022-11-22 |
2022-11-18 |
PS
Planned sale
|
Papapetropoulos Spyros
Chief Medical Officer
Officer
|
300
-7.0%
14.00
USD 4,200
|
300
-7.0%
|
14.00
|
USD 4,200
|
|
2022-05-17 |
2022-05-17 |
B
Purchase
|
Thorp Clay
Non-Executive Director
|
14,893
+1.0%
2.97
USD 44,189
|
14,893
+1.0%
|
2.97
|
USD 44,189
|
|
2022-05-17 |
2022-05-16 |
B
Purchase
|
Thorp Clay
Non-Executive Director
|
21,802
+1.4%
2.76
USD 60,221
|
21,802
+1.4%
|
2.76
|
USD 60,221
|
|
2022-05-06 |
2022-05-05 |
B
Purchase
|
Thackaberry Evan
SVP, Head of Early Development
Officer
|
1,500
+inf%
4.00
USD 6,000
|
1,500
+inf%
|
4.00
|
USD 6,000
|
|
2022-05-04 |
2022-05-03 |
B
Purchase
|
Verni Christopher
General Counsel
Officer
|
4,000
+inf%
3.77
USD 15,074
|
4,000
+inf%
|
3.77
|
USD 15,074
|
|
2022-05-04 |
2022-05-03 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
1,000
+0.5%
3.94
USD 3,940
|
1,000
+0.5%
|
3.94
|
USD 3,940
|
|
2022-05-04 |
2022-05-03 |
B
Purchase
|
Ziolkowski Jennifer Lynn
Chief Financial Officer
Officer
|
4,000
+inf%
3.77
USD 15,098
|
4,000
+inf%
|
3.77
|
USD 15,098
|
|
2022-05-04 |
2022-05-03 |
B
Purchase
|
Papapetropoulos Spyros
Chief Medical Officer
Officer
|
4,000
+inf%
3.40
USD 13,591
|
4,000
+inf%
|
3.40
|
USD 13,591
|
|
2022-05-04 |
2022-05-02 |
B
Purchase
|
Magovcevic-Liebisch Ivana
President and CEO
Executive Director
|
4,000
+2.0%
3.61
USD 14,439
|
4,000
+2.0%
|
3.61
|
USD 14,439
|
|
2022-03-28 |
2022-03-28 |
B
Purchase
|
Thorp Clay
Non-Executive Director
|
3,000
+inf%
7.20
USD 21,604
|
3,000
+inf%
|
7.20
|
USD 21,604
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Booth Bruce
Non-Executive Director
|
535,000
+12.5%
14.00
USD 7,490,000
|
535,000
+12.5%
|
14.00
|
USD 7,490,000
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Northpond Ventures GP, LLC
Large shareholder
|
355,000
+34.5%
14.00
USD 4,970,000
|
355,000
+34.5%
|
14.00
|
USD 4,970,000
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Vida Ventures GP III, L.L.C.
Large shareholder
|
3,852
+50.1%
14.00
USD 53,928
|
3,852
+50.1%
|
14.00
|
USD 53,928
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Vida Ventures GP III, L.L.C.
Large shareholder
|
1,671,148
+50.1%
14.00
USD 23,396,072
|
1,671,148
+50.1%
|
14.00
|
USD 23,396,072
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Vitorovic Stefan
Non-Executive Director
|
3,852
+50.1%
14.00
USD 53,928
|
3,852
+50.1%
|
14.00
|
USD 53,928
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Vitorovic Stefan
Non-Executive Director
|
1,671,148
+50.1%
14.00
USD 23,396,072
|
1,671,148
+50.1%
|
14.00
|
USD 23,396,072
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Atlas Venture Fund XII, L.P.
Large shareholder
|
535,000
+12.5%
14.00
USD 7,490,000
|
535,000
+12.5%
|
14.00
|
USD 7,490,000
|
|
2022-01-11 |
2022-01-11 |
B
Purchase
|
Thorp Clay
Non-Executive Director
|
265,000
+21.1%
14.00
USD 3,710,000
|
265,000
+21.1%
|
14.00
|
USD 3,710,000
|
|